ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

Matched-related bone marrow transplantation (BMT) may cure >80% of low-risk children with severe thalassemia (ST). Very long-term follow-up studies have shown how the standard busulfan-cyclophosphamide (BuCy) regimen may be associated with normalization of health-related quality of life, no secon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Faulkner, Lawrence, Uderzo, Cornelio, Khalid, Sadaf, Marwah, Priya, Soni, Rajpreet, Yaqub, Naila, Amanat, Samina, Fatima, Itrat, Gilani, Sarah Khan, Zahra, Tatheer, Ramprakash, Stalin, Gooneratne, Lallindra, Dissanayake, Ruwangi, Williams, Senani, Rathnayake, Wasantha, Srinivas, Reshma, Sedai, Amit, Kumari, Ankita, Parmar, Lailith, Dhanya, Rakesh, Agarwal, Rajat Kumar
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727808/
https://ncbi.nlm.nih.gov/pubmed/29296723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016004119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados